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SUMMARY 
Calcium-dependent action potentials were recorded from mouse spinal cord 
neurons in primary dissociated cell culture following addition of the potassium 
channel blockers tetraethylammonium ion and 3-aminopyridine. The pharmaco- 
logically active barbiturates, pentobarbital and phenobarbital, but not the pharma- 
cologically inactive barbiturate, barbituric acid, produced reversible, dose-dependent 
reduction of action potential duration at sedative-hypnotic and anesthetic concentra- 
tions. Pentobarbital reduced action potential duration at concentrations from 25 to 
600/~M (50~o reduction at 170/~M) while phenobarbital reduced action potential 
duration at concentrations from 100 to 5000/~M (50 ~ reduction at 9130 pM). The 
barbiturate concentrations which reduced calcium-dependent action potential dura- 
tion in this study correlate with reduction of  neurotransmitter release from other 
neuronal preparations and with reduction of calcium uptake by synaptosomes. The 
results suggest that barbiturates may produce anesthesia in part by reduction of 
presynaptic calcium entry and consequent reduction of neurotransmitter release in 
addition to postsynaptic increase of  membrane chloride ion conductance. Barbiturate 
anticonvulsant actions are probably due to postsynaptic augmentation of GABA- 
mediated inhibition and depression of excitatory synaptic transmission. The major 
difference between anticonvulsant (phenobarbital) and anesthetic (pentobarbital) bar- 
biturates was the dose-dependency of these actions. Phenobarbital produced post- 
synaptic modulation of neurotransmitter responses at low concentrations and 
decreased calcium-dependent action potential duration and increased chloride ion 
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conductance at high concentrations. In contrast, pentobarbital produced all actions at 
low concentrations. Thus for phenobarbital there would be a large therapeutic index 
for anticonvulsant activity compared to anesthetic activity but for pentobarbital there 
would be a small therapeutic index. 
INTRODUCTION 
Barbiturates are used clinically as anticonvulsants, sedative-hypnotics and 
anestheticslT,4L Long-acting barbiturates such as phenobarbital and mephobarbital 
are useful as chronic anticonvulsants since they have little sedative action at 
therapeutic serum concentrations. Intermediate and short acting barbiturates such as 
pentobarbital, thiopental or amobarbital are efffective anticonvulsants but cannot be 
administered chronically due to their sedative side effects; therefore, they are used 
primarily as sedative-hypnotics or anesthetics. What are the mechanisms of barbi- 
turate anticonvulsant, sedative-hypnotic and anesthetic action, and why do barbitu- 
rates differ in their clinical usefulness as anticonvulsants and anesthetics? 
Barbiturates have both synaptic and non-synaptic (membrane) actions in the 
central nervous system. Barbiturates act: (1)postsynaptically to increase GABA- 
mediated inhibition 2,12,26-2s,31,a2,37,42,48,49, to reduce glutamate 2,26-28,32,45,49, as- 
partate 32 and acetylcholinel, 34 mediated excitation, and to directly activate GABA- 
receptors thus increasing membrane chloride conductance26,28,32,49; (2)presynapti- 
cally to block release of neurotransmitters°,15,25,29, 44,5a,54,5°, including GABA7,9,10, 
18,55, glutamatelO,38,55, aspartate38,55,57, acetylcholine20,24,29,46,47,55 and norepineph- 
rine is, and (3) directly or non-synaptically 51 on neuronal membranes to reduce sodium 
and potassium conductances3,30, 50. 
Since modulation of amino acid responses by the anticonvulsant barbiturate 
phenobarbital has been demonstrated at concentrations that are present in brain when 
anticonvulsant serum levels are therapeutic 49, it is likely that barbiturates have 
anticonvulsant action by postsynaptic enhancement of GABAergic inhibitory and 
reduction of excitatory synaptic transmission 20-28. 
Barbiturates may produce anesthesia by a combination of pre- and postsynaptic 
mechanisms. First, direct increase of postsynaptic chloride conductance by the 
anesthetic barbiturate pentobarbital was produced at high anesthetic barbiturate 
concentrations 49. Chloride conductance increase would produce membrane hyper- 
polarization and thus postsynaptic inhibition. Second, since release of neurotrans- 
mitter is calcium-dependent11,14, requiring entry of calcium through voltage-de- 
pendent presynaptic calcium channels2~, 22 and since barbiturates have been shown to 
block the uptake of calcium by presynaptic terminals 4,~,a5, it has been suggested that 
barbiturates reduce transmitter release by antagonizing calcium entry into presynaptic 
terminals4,5, 35. Essential to this hypothesis of anesthetic action is the demonstration 
that barbiturates reduce the voltage-dependent inward calcium current in presynaptic 
terminals at anesthetic barbiturate concentrations. While it is not ieasible to record 
from presynaptic terminals of mammalian neurons, calcium-dependent action poten- 
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tials can be recorded from somata of mouse spinal cord neurons in cell culture if 
membrane potassium conductance is reduced 19. Therefore, we have studied the 
actions of barbiturates on somatic calcium-dependent action potentials under the 
assumption that calcium conductance of neuronal somata and synaptic terminals are 
similar. 
In the present study, we have shown that pentobarbital and phenobarbital, but 
not barbituric acid, reduced calcium-dependent action potential duration at sedative- 
hypnotic and at anesthetic drug concentrations. Thus barbiturate anesthesia may be 
due in part to: (1) blockade ofpresynaptic calcium entry and consequent reduction of 
neurotransmitter release, as well as to (2) direct postsynaptic enhancement of chloride 
conductance and consequent membrane hyperpolarization. 
METHODS 
Primary dissociated cell culture 
Dissociated neuronal cell cultures were prepared from dissected spinal cords and 
attached dorsal root ganglia from 12-13.5-day-old fetal mice as described previous- 
ly 4a. Following trypsinization and mechanical dissociation by trituration, the cells 
were plated on collagen-coated 35 mm culture dishes. The cultures were maintained in 
a growth medium containing 80 ~ minimal essential medium, 10 ~ fetal calf serum 
and 10 ~ heat-activated horse serum at a pH of 7.3-7.4 and osmolarity 340 mOsm. 
Between days 6 and 8, uridine and 5'-fluoro-2'-deoxyuridine were added to suppress 
growth of non-neuronal cells. The growth medium was changed twice a week. The 
cultures were incubated at 35-37 °C in an atmosphere enriched with 10~o carbon 
dioxide for 4-6 weeks prior to electrophysiological recording. 
Intracellular recording 
Neurons were visualized on the stage of an inverted phase contrast microscope 
modified to maintain the culture plate at 35-37 °C. Intracellular recordings were made 
from large multipolar spinal cord neurons (>  20/~m diameter) using omega dot glass 
microelectrodes filled with 4 M potassium acetate (KAc) (25-50 Mf~) connected to a 
unity gain high impedance amplifier and conventional bridge circuit (WPI M 707) to 
permit simultaneous measurement of membrane potential and injection of current 
through a single microelectrode. Data were recorded on a 6-channel Brush recorder 
and photographed from the screen of a Tektronix storage oscilloscope (Grass camera 
mounted with Bioelectric Refiexor). 
Solutions 
All recordings were made in balanced salt solutions (total volume 2.5 ml) after 
removal of growth medium. Heavy parafin oil was applied to the surface of the 
bathing solution to retard evaporation, unless the bathing solution was to be changed 
during the course of the experiment. The basic solution (referred to as control bathing 
solution) was adjusted to pH 7.30-7.40 and osmolarity 305-325 mOsm. It consisted of 
(in mM): NaCI 137.5; KCI 5.3; CaC12 5.0; glucose 5.6; MgC12 0.8; and Tris-HC1 13. 
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When tetraethylammonium (TEA) (25 mM) and 3-aminopyridine (3-AP) (5 mM) were 
added to the bathing solution, the sodium chloride concentration was lowered to 115 
mM to keep the solution osmolarity constant. Tetrodotoxin (TTX) was added from a 
1 mM stock solution directly to the bathing solutions, final concentration was either 1 
or 3/~M prior to addition to the culture plate. 
Stock solutions (100 mM) of the barbiturates (sodium salts) were prepared in 
control solution containing TEA and 3-AP on the day of the experiment. Aliquots of 
these stock solutions were removed and added to the bathing solutions to make final 
test concentrations (30-2000/~M). The pH was measured and adjusted to between 7.30 
and 7.40 when necessary. Barbiturates were stable in aqueous solution for the length of 
the experiments (6-8 h). 
Super fusion 
Known concentrations of barbiturates were applied to individual neurons 
during intracellular recordings by the technique of superfusion. The bathing solution 
in the culture dish was completely exchanged by test solutions made up of bathing 
solution plus barbiturates at physiological pH, constant osmolarity and constant 
temperature (35-37 °C). Solutions were delivered to and removed from the 35 mm 
culture dish using a peristaltic pump adjusted to a rate of 0.5-1 ml/min. Exchange was 
considered complete only after 3 times the original bathing solution volume was 
superfused through the culture dish. In many cases 10 or more 'complete' exchanges 
were performed while recording intracellularly from a single spinal cord neuron. 
Miniperfusion 
Barbiturates could also be applied to the neuronal surface during intracellular 
recording by the technique of miniperfusion. A microelectrode whose tip was 
manually broken to a diameter of 2-10/~m was filled with test solution. Test solution 
consisted of bathing solution with barbiturates. The open end of each miniperfusion 
pipette was connected to a pressure regulator by tight fitting polyethylene tubing. 
Pressure pulse durations were regulated by a voltage-activated 3-way valve. Closure of 
the valve switched the miniperfusion pipette pressure from atmospheric to that 
selected on the pressure regulator (0.5-2.0 pounds per square inch (psi)). Test solutions 
were applied to the recorded neuron by positioning the miniperfusion pipette 10-50 
#m from the neuronal surface following generation of a control action potential and 
removing it 1-3 s before the next stimulated action potential. Small hyperpolarizing 
artifacts (-< 5 mV) were occasionally produced by miniperfusion, but these could be 
minimized by using small diameter miniperfusion pipettes, low miniperfusion pres- 
sure, more distant placement of the electrode and removal of the electrode prior to 
stimulation. No change in membrane conductance was seen during the hyper- 
polarizing artifact. The miniperfusion pipettes (usually 3) and recording micro- 
electrodes were held by Leitz micromanipulators. To decrease leakage of barbiturate 
into the bathing medium, the tips of the miniperfusion electrodes were kept in the oil 
phase between drug application trials. They were lowered into the aqueous phase only 
during the interstimulus interval when drug application was desired. 
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Percentage shortening of calcium-dependent action potential duration 
Action potential durations were measured at half maximal action potential 
amplitude. Percentage shortening of action potential durations was determined, and 
the percentage shortening of duration after application of barbiturate was compared 
to the control duration before drug application. 
RESULTS 
Sodium- and calcium-dependent action potentials 
In all experiments, recordings were obtained f rom spinal cord neurons. As 
previously reported 19, action potentials recorded from the somata of  spinal cord 
neurons in control bathing solution were brief in duration (0.6 ms) (Fig. 1A). The 
rising phase of the action potential required sodium ions and was blocked by the 
sodium conductance blocker TTX. Addition of TTX, 25 mM TEA and 5 mM 3-AP to 
the bathing solution increased the average input resistance from 22.0 4- 4.4 Mf~ (:~ 
standard error of  the mean (S.E.M.)) (10 neurons) to 57.4 :~ 11.6 M f l  (8 neurons) and 
in about  50 ~ of the neurons long-duration action potentials which were calcium- 
dependent could be elicited by depolarizing stimuli (Fig. 1B). Calcium-dependent 
action potentials could be elicited in a higher percentage of spinal cord neurons if the 
concentration of TEA was increased above 50 mM;  however, at these concentrations 
the neurons deteriorated morphologically. The duration of the calcium-dependent 
action potentials in different neurons varied f rom 10 to 400 ms. 
Phenobarbital and pentobarbital reduced calcium-dependent action potential duration 
Application of phenobarbital  and pentobarbital, but not barbituric acid, short- 
ened calcium-dependent action potentials. Action potentials were elicited by intra- 
cellular depolarizing stimuli every 30 s (Fig. 2A, B). Control action potentials in this 
and subsequent figures were denoted by '1' (Fig. 2A, B); after superfusion of 3 ml of  
phenobarbi ta l  (2000 #M)  or pentobarbital  (300 #M), the action potential was 
1/~, 18 CONTROL TEA/5"AP 
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Fig. 1. Action potentials elicited from spinal cord neurons in control bathing solution (A) and bathing 
solution containing tetraethylammonium (TEA) and 3-aminopyridine (3-AP) (B). Action potentials 
were elicited from resting membrane potential (RMP) after brief depolarizing stimuli; stimulus onset 
in this and subsequent figures is denoted by filled triangles. The action potentials were recorded 
intracellularly in different bathing solutions: A was recorded in control bathing solution as described 
in Methods, and B in control bathing solution containing 25 mM TEA, 5 mM 3-AP and 3 ffM TTX. 
Sodium chloride was reduced to 115 mM to maintain isosmolarity. Stimulus pulse duration and RMP 
were: A, 0.4 ms, --62 mV; B, 10 ms, --56 rnV. This and subsequent figures were retouched to remove 
grid markings, and to fill in the rising phase of the action potentials when reproduced faintly. 
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Fig. 2. Phenobarbital (PhB) and pentobarbital (PB) shortened calcium-dependent action potentials in 
spinal cord neurons. Superimposed calcium-dependent action potentials prior to (1) and after 
superfusion of 2000 #M PhB (A) and 300/zM PB (B). The action potentials in A and B were elicited 
with 10 ms depolarizing pulses every 30 ms. 5 and 6 are the fith and sixth action potentials elicited after 
superfusion of PhB or PB. 1, 5 and 6 are to the left of their respective action potentials. RMP were: A, 
--52 mV and B, --50 mV. The bathing solution was control bathing solution with 25 mM TEA, 5 mM 
3-AP and 3 ffM TTX. 
shor tened by  58 ~ (Fig.  2A) and 45 ~ (Fig.  2B). In  add i t ion  to shor tening o f  act ion 
poten t ia l  dura t ion ,  the p la teau  ampl i tude  o f  the ac t ion potent ia l  decreased.  
Shor ten ing  o f  ac t ion potent ia l  dura t ion  was dose-dependent .  Superfusion of  
phenobarb i t a l  at  3 different concentra t ions  (500, 1000 and  2000 p M )  onto  the same 
neuron  p roduced  progressively greater  percentage shortening o f  the ac t ion potent ia l  
du ra t ion  (Fig. 3A1, A2, A3). A similar  reduct ion  of  ac t ion potent ia l  dura t ion  was seen 
with superfus ion o f  pen tobarb i t a l  onto  ano ther  neuron  at  3 different concent ra t ions  
(100, 200 and 300 # M )  (Fig.  3B1, B2, B8). The number  '2 '  (Fig. 3) denotes  the ac t ion 
poten t ia l  el ici ted after twice the init ial  volume o f  ba th ing  solut ion was exchanged.  
Af ter  drug  appl ica t ion ,  5 t imes the volume o f  cont ro l  solut ion was superfused th rough  
the culture.  'Con t ro l '  ac t ion potent ia l  dura t ions  recorded before and after  ba rb i tu ra te  
3 
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Fig. 3. Phenobarbital (PhB) and pentobarbital (PB) shortening of calcium-dependent action potentials 
was dose-dependent. PhB and PB were applied to spinal cord neurons by superfusion. Superimposed 
calcium-dependent action potentials stimulated with 10 ms depolarizing pulses every 30 s prior to (1) 
and after (2) superfusion of 500 (A1), 1000 (AD or 2000 ffM (Az) PhB, and 100 (BD, 200 (B2) or 300 ffM 
(B3) PB. 1 and 2 are to the right and left of their action potentials, respectively. A1, A2 and As were 
recorded from the same neuron (RMP --58 mV); B1, B2 and B3 were recorded from the same neuron 
(RMP --55 mV). The bathing solutions were control bathing solution with 25 mM TEA, 3 ffM TTX 
in both A1, As, As and B1, Be, Ba and 5 mM 3-AP only in A1, As, A3. 
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Fig. 4. Phenobarbital (PhB) and pentobarbital (PB) shortening of calcium-dependent action potentials 
was dose-dependent. PhB (filled triangles), PB (filled circles) and barbituric acid (BA) (filled square) 
were applied to spinal cord neurons by superfusion. Action potential duration was determined at half 
maximal amplitude. Percentage shortening is the percentage decrement in duration of the action 
potential after application of barbiturate compared to the control duration. This percentage 
shortening was plotted as a function of barbiturate concentration. Different doses of PhB or PB were 
applied onto the same neuron. Each new dose of barbiturate was superfused only after the neuron had 
been returned to bathing solution without barbiturate and the action potential duration returned to 
within 20 ~ of its previous control value. BA was superfused twice during experiments of either PB or 
PhB. The filled triangles or circles were averages of shortening tested on 4-11 neurons. The bars above 
and below these averages were their standard errors of the mean (S.E.M.). The bathing solution 
contained control solution plus 25 mM TEA, 5 mM 3-AP and 3 # M  TTX. 
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Fig. 5. Phenobarbital (PhB) and pentobarbital (PB) decreased conductance during the plateau of 
calcium-dependent action potentials. Superimposed calcium-dependent action potentials were elicited 
by 5 ms depolarizing stimuli every 30 s. Control action potentials (labeled '1' in A1, A2, B1 and Bz) 
were elicited before application of 500 ffM PhB (A1 and A~) and 100 ffM PB (B1 and B2). 2 denotes the 
action potential elicited 6 s after a 4 s pressure pulse ejected either PhB or PB. A~ and B2 are high gain 
records of the action potential plateau before (1) or after (2) barbiturate application. 1 and 2 are 
separated by displacing the oscilloscope trace. A constant current pulse was superimposed on the 
plateau at a time indicated by the filled circles (A~ and B2). All records (A1, A2, B1 and B2) were 
obtained from the same spinal cord neuron. R MP was - -57 inV. The bathing solution was control 
bathing solution with 25 mM TEA, 5 mM 3-AP and 1 ffM TTX. 
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exposure differed by less than 20 ~ in most experiments. Using superfusion, complete 
dose-response curves could be generated on single neurons (Fig. 4) with 6 different 
concentrations of barbiturate separated by 6 washings with drug-free medium. Each 
point on the dose-response curve was the average percentage shortening at each dose 
of barbiturate (Fig. 4). Pentobarbital was more potent than phenobarbital in pro- 
ducing action potential shortening. Pentobarbital shortened calcium-dependent action 
potentials over a 25-600 /zM range with a 50~  shortening at about 170 /zM. 
Phenobarbital reduced calcium action potential duration over a 100-5000/zM range 
with a 50~  shortening at about 900/~M. Barbituric acid (2 mM) did not reduce 
calcium-dependent action potential duration (Fig. 4; filled square). 
Phenobarbital and pentobarbital decreased action potential plateau conductance 
Miniperfusion of either phenobarbital (500/~M) or pentobarbital (100/~M) onto 
spinal cord neurons shortened the action potential duration ('2' in Fig. 5A1, B1). 
Shortening of the action potential could have been produced by a decrease in calcium- 
conductance and/or by an increase in potassium or chloride conductance. To 
determine membrane conductance during action potential plateau, short constant 
current pulses(10 ms in duration) were superimposed on calcium-dependent action 
potentials before ('1' in Fig. 5A2, B2) and after ('2' in Fig. 5A2, Bz) miniperfusion of 
500/~M phenobarbital (Fig. 5A2) and 100/~M pentobarbital (Fig. 5B2). The potential 
produced in response to constant current pulses increased in amplitude after applica- 
tion of 500/zM phenobarbital ('2' Fig. 5A2) and 100/~M pentobarbital ('2' Fig. 5B2) 
compared to control ('1' in Fig. 5A2, B2), indicating decreased conductance. 
DISCUSSION 
Barbiturates and calcium-dependent action potentials 
We have demonstrated that the pharmacologically active barbiturates pheno- 
barbital and pentobarbital, but not the pharmacologically inactive barbiturate, 
barbituric acid, decreased the duration of calcium-dependent action potentials in 
mouse spinal cord neurons in cell culture. Action potential duration is determined by 
the relative magnitude of depolarizing inward current (in this case calcium current) 
and hyperpolarizing outward currents (potassium and chloride currents). Action 
potential shortening could have been preduced, therefore, by a reduction of calcium 
conductance or by an enhancement of either potassium or chloride conductances. 
Several lines of evidence suggest that barbiturates reduce calcium conductance. At 
anesthetic concentrations, pentobarbital reduced the calcium influx induced by 
potassium depolarization of mouse brain synaptosomesS,13,2z, 35 and rat sympathetic 
ganglia 4 and by preganglionic stimulation in rat sympathetic ganglia 4 (Table I). 
Pentobarbital also reduced the maximum rate of rise (~'max) of calcium dependent 
action potentialsin the R2 neuron of Aplysia abdominal ganglia a6. Since the recordings 
were made in sodium-free medium, ~max was a measure of an early inward calcium 
current. However, pentobarbital and phenobarbital have also been shown to increase 
membrane chloride conductance of frog spinal motoneurons and dorsal root af- 
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TABEL I 
One-half maximal or average effective concentrations (range of effective concentrations) 
Plasma barbiturate concentrations were calculated assuming full distribution in total body water 
(70 % body weight) and brain barbiturafe concentrations were calculated assuming a brain to plasma 
ratio of 0.75. 
Pentobarbital ( I ~ M )  Phenobarbital (ttM) 
GABA augmentation 4° 50 (10~00) 
Anticonvulsant action 40 75 (50-100) 
Reduced calcium-dependent 
action potential duration* 170 (25-600) 
Reduction of synaptically evoked 
spontaneous activity 49 250 (100-500) 
Reduced release of ACh from the 
vagal innervation of the heart 24 170 (50-500) 
Reduced release of ACh from 
midbrain slices 47 297 (50-1000) 
Reduction of Ca 2+ uptake of 
synaptosomes 5 450 (50-1600) 
Increased membrane chloride 
conductance 49 (100-500) 
Neurotoxic or sedative action 40 75 (50-100) 









* Data from the present study. 
ferentsZ2, 3a and mouse spinal cord neurons in cell culture 26,28,49 at high anesthetic 
concentrations. The direct barbiturate action was blocked by the GABA-antagonists 
picrotoxin, bicuculline and penicillin and thus was probably due to an interaction with 
GABA receptors. Since barbiturates did not displace [ZH]GABA from its binding sites 
on brain membranes 86, it is unlikely that barbiturates bind to the active GABA 
recognition site but rather they probably bind to a coupling site between the GABA-  
binding site and the chloride channel. Finally, barbiturates have been shown to 
increase a slowly developing voltage-dependent potassium conductance in Aplysia 
neurons at anesthetic concentrations s. In the present experiments, pentobarbital and 
phenobarbital  increased the amplitude of short, small hyperpolarizing constant 
current pulses applied during the action potential plateau. Since the hyperpolariza- 
tions were small, their amplitudes were proportional to the membrane conduc- 
tance during the plateau. An increase in the amplitude of the pulses suggested that net 
membrane conductance was reduced, consistent with a primary barbiturate action on 
calcium conductance. This does not exclude the possibility that barbiturates reduced 
calcium-dependent action potential duration by increasing potassium and/or chloride 
conductance. Direct measurement of  calcium, chloride and potassium currents using 
the voltage clamp technique would be required to determine which ionic conductance 
is involved in action potential shortening. 
Barbiturates may reduce release of  neurotransmitter by blocking presynaptic calcium 
entry 
Pentobarbital  reduced the amplitude of the monosynaptic L7 ventral root reflex 
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responses evoked by stimulation of the triceps surae nerve 56. Quantal analysis of 
excitatory postsynaptic potentials recorded in motoneurons which were evoked by 
stimulation of single group Ia afferent fibers demonstrated that pentobarbital reduced 
the presynaptic release of neurotransmitter without altering the postsynaptic response 
to the neurotransmitter. Pentobarbital reduced the quantal content 24.7~ at a 
subanesthetic intravenous dose (10 mg/kg). Assuming uniform distribution in total 
body water (70 ~ of total body weight) and a brain to plasma ratio for PB of 0.75, the 
barbiturate concentration in spinal cord would have been about 45 pM. In the present 
study, pentobarbital reduced the calcium-dependent action potential by about 10 ~ at 
45 #M. 
Furthermore, pentobarbital reduced acetylcholine release from vagal terminals 
in chicken heart evoked by field stimulation 24 and from rat cortical, striatal, hippo- 
campal, midbrain and pons-medulla slices evoked by potassium-induced depolariza- 
tion 46,47,55 at concentrations ranging from 50 to 500 or 1000/~M (Table I) and reduced 
release of GABA 7,9,1°,x8, glutamate1°, ~8, aspartate ~8,57 and norepinephrinO s from 
cortical synaptosomes at concentrations above 100/zM. Phenobarbital reduced acetyl- 
choline release from rat midbrain slices 47 over a higher concentration range (200-2000 
/~M) (Table I) but did not significantly reduce release of GABA, aspartate or 
glutamate from rat cortex at 1 mM 1°. In mouse spinal cord neurons in cell culture, 
pentobarbital reduced synaptically driven spontaneous activity at concentrations of 
100-500/~M (50~ of cells having no spontaneous activity at 250/~M) (Table 1) 49. 
Phenobarbital also reduced synaptically driven spontaneous activity but at the higher 
concentrations of 500-2500/tM (50 ~ of cells having no spontaneous activity at 1250 
/~M) (Table I) 49. Calcium uptake by rat brain synaptosomes was reduced by pento- 
barbital 5 over a concentration range (50-1600/~M (Table I) similar to that reducing 
transmitter release, while phenobarbital produced only a small (15~) decrease in 
calcium uptake at 900/~M 5. 
In the present study, calcium action potential duration was reduced by pento- 
barbital over the same concentration range (25-600/~M) (Table l) effective in reducing 
neurotransmitter release and synaptosomal calcium uptake. Phenobarbital also re- 
duced calcium-dependent action potential duration but over a higher concentration 
range (100-5000/~M) (Table 1), similar to that necessary for reduction of neuro- 
transmitter release. Thus, it is likely that barbiturates reduce release of neurotrans- 
mitters from presynaptic terminals by reducing presynaptic calcium entry. 
Mechanism of  barbiturate an ticon vulsant and anesthetic actions 
Barbiturates have multiple actions on neurons but these actions are produced at 
different barbiturate concentrations. For a specific barbiturate action to have signifi- 
cance for its clinical mechanism of action, it must occur at clinically relevant 
concentrations. Both phenobarbital and pentobarbital have anticonvulsant actions, 
but only phenobarbital is used in ambulatory patients due to the undesirable sedative 
side effects of pentobarbital. Plasma phenobarbital levels of 43-129 #M (I 0-30/~g/ml) 
are within the therapeutic range in humans, but brain to plasma phenobarbital ratios 
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Fig. 6. Dose-dependency of phenobarbital actions on GABA responses, calcium-dependent action 
potentials and membrane chloride ion conductance. Phenobarbital: (1) augmented GABA responses 
produced iontophoretically (filled circles); (2) reduced calcium-dependent action potential duration 
(filled triangles), and (3) increased membrane chloride ion conductance in mouse spinal cord neurons 
in cell culture. Data on GABA augmentation and reduction of chloride ion conductance are from 
Schulz and Macdonald 49. 
be about 30-90/~M. Similarly, phenobarbital had anticonvulsant action in rats against 
pentylenetetrazol (PTZ) and maximal electroshock (MES) seizures from about 14-28 
mg/kg when administered intraperitoneally 40. Brain phenobarbital concentrations 
should have been about 60--120 #M. Phenobarbital augmented GABA responses on 
spinal cord neurons in cell culture over a 20-500/~M range 49 (Fig. 6; Table I) and 
reduced glutamate responses at similar concentrations zT. 
Sedative or neurotoxic actions of  phenobarbital in rats were produced from 
40-80 mg/kg when administered intraperitoneally 40. Brain phenobarbital levels should 
have been about 180-360 #M corresponding to reduction of calcium-dependent 
action potential duration of  about 10-25 ~ (Fig. 6; Table I). Phenobarbital produced 
anesthesia at brain concentrations greater than 500/tM 7 corresponding to a reduction 
of calcium-dependent action potential duration of about 35 ~ (Fig. 6; Table 1). 
Phenobarbital also increased chloride conductance at concentrations greater than 500 
/.tM 49 (Fig. 6; Table I). 
Pentobarbital had anticonvulsant actions in rats against PTZ and MES seizures 
from 12-24 mg/kg when administered intraperitoneally 40. Brain pentobarbital levels 
should have been about 50-100 /_tM (Table I). Pentobarbital augmented GABA 
responses over a similar concentration range (10-400/tM) 49. Pentobarbital produced 
neurotoxic (sedative) actions at similar brain concentrations (50-100 /zM) 4° and 
produced anesthesia at slightly higher concentrations (150-225/tM) 44. Pentobarbital 
reduced calcium action potential duration 15-30 ~ at neurotoxic (sedative) concentra- 
tions and 40-60 ~o at anesthetic concentrations (Fig. 7; Table I). Pentobarbital also 
increased chloride ion concentration at anesthetic concentrations ( >  150/~M) (Fig. 7; 
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Fig. 7. Dose-dependency of pentobarbital actions on GABA responses, calcium-dependent action 
potentials and membrane chloride ion conductance. Pentobarbital: (1) augmented GABA-responses 
produced iontophoretically (filled circles); (2) reduced calcium-dependent action potential duration 
(filled triangles), and (3) increased membrane chloride ion conductance in mouse spinal cord neurons 
in cell culture. Data on GABA augmentation and reduction of chloride ion conductance are from 
Schulz and MacdonaldaL 
in anticonvulsant, sedative-hypnotic or anesthetic actions since voltage-dependent 
sodium and potassium conductances were reduced only at high barbiturate concen- 
trations ( >  500/tM)3,30, 5°. 
Thus postsynaptic augmentation of GABA-mediated inhibition and antagonism 
of excitatory synaptic transmission occurred at anticonvulsant barbiturate concentra- 
tions. Neurotoxic (sedative) actions occurred at barbiturate concentrations which re- 
duced calcium-dependent action potential duration 10-30~.  Anesthesia occurred at 
barbiturate concentrations which reduced calcium-dependent action potential duration 
greater than 35 ~ and directly increased postsynaptic chloride conductance. Barbiturate 
anticonvulsant action was therefore correlated with postsynaptic modulation of amino 
acid responses. Neurotoxic (sedative) actions were correlated with addition of some pre- 
synaptic reduction of transmitter release to postsynaptic amino acid response modula- 
tion. Anesthesia was correlated with an increase in inhibition of transmitter release and 
direct postsynaptic increase in chloride ion conductance in addition to the post- 
synaptic amino acid response modulation. These results also suggest that anticon- 
vulsant and anesthetic barbiturates differ only in the dose dependency of their actions. 
Phenobarbital is useful as an anticonvulsant in ambulatory patient because there is a 
good therapeutic index between amino acid modulation (anticonvulsant action) and 
reduction of  transmitter release and increase of  chloride ion conductance (sedative and 
anesthetic actions). Pentobarbital is useful only for sedation and anesthesia because 
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